Association of Hashimoto's thyroiditis and thyroid cancer

Current Opinion in Oncology

Volumn 27, Issue 1, 2015, Pages 21-25

  Noureldine, Salem I ^a   Tufano, Ralph P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic lymphocytic thyroiditis; Hashimoto's thyroiditis; Lymphoma; Papillary; Thyroid cancer

Indexed keywords

8 HYDROXYGUANINE; B RAF KINASE; CD98 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P63; TUMOR MARKER;

ANTIGEN EXPRESSION; CANCER INCIDENCE; CANCER PROGNOSIS; DIFFERENTIATED THYROID CANCER; DISEASE ASSOCIATION; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; HASHIMOTO DISEASE; HUMAN; LYMPHOCYTIC INFILTRATION; ONCOGENE; ONCOGENE RET; PREVALENCE; PTC ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; THYROID CANCER; THYROIDECTOMY; AUTOIMMUNE THYROIDITIS; COMPLICATION; GENETICS; METABOLISM; PAPILLARY CARCINOMA; PATHOLOGY; RISK FACTOR; THYROID TUMOR;

CARCINOMA, PAPILLARY; HUMANS; RISK FACTORS; THYROID NEOPLASMS; THYROIDITIS, AUTOIMMUNE; TUMOR MARKERS, BIOLOGICAL;

EID: 84916939495     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0000000000000150     Document Type: Review

References (42)

1. Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: The influence of access to care. Thyroid 2013; 23: 885-891.
2. Li N, Du XL, Reitzel LR, et al. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: Review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid 2013; 23: 103-110.
3. Larson SD, Jackson LN, Riall TS, et al. Increased incidence of well differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg 2007; 204: 764-773.
4. Farrow B, Evers BM. Inflammation and the development of pancreatic cancer. Surg Oncol 2002; 10: 153-169.
5. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001; 357: 539-545.
6. Cipolla C, Sandonato L, Graceffa G, et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg 2005; 71: 874-878.
7. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-2167.
8. Zhang Y, Dai J, Wu T, et al. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. J Cancer Res Clin Oncol 2014; 140: 1021-1026.
9. Oh CM, Park S, Lee JY, et al. Increased prevalence of chronic lymphocytic thyroiditis in Korean patients with papillary thyroid cancer. PLoS One 2014; 9: E99054.
10. Derringer GA, Thompson LD, Frommelt RA, et al. Malignant lymphoma of the thyroid gland: A clinicopathologic study of 108 cases. Am J Surg Pathol 2000; 24: 623-639.
11. Kossev P, Livolsi V. Lymphoid lesions of the thyroid: Review in light of the revised European-American lymphoma classification and upcoming World Health Organization classification. Thyroid 1999; 9: 1273-1280.
12. Rossi D. Thyroid lymphoma: Beyond antigen stimulation. Leuk Res 2009; 33: 607-609.
13. Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 1955; 70: 291-297.
14. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312: 601-604.
15. Jankovic B, Le KT, Hershman JM. Clinical review: Hashimoto's thyroiditis and papillary thyroid carcinoma: Is there a correlation? J Clin Endocrinol Metab 2013; 98: 474-482.
16. Tamimi DM. The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol 2002; 10: 141-146.
17. Eisenberg BL, Hensley SD. Thyroid cancer with coexistent Hashimoto's thyroiditis. Clinical assessment and management. Arch Surg 1989; 124: 1045-1047.
18. Schaffler A, Palitzsch KD, Seiffarth C, et al. Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma. Eur J Clin Invest 1998; 28: 838-844.
19. Okayasu I, Fujiwara M, Hara Y, et al. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 1995; 76: 2312-2318.
20. Scarpa V, Kousta E, Tertipi A, et al. Treatment with thyroxine reduces thyroid volume in euthyroid children and adolescents with chronic autoimmune thyroiditis. Horm Res Paediatr 2010; 73: 61-67.
21. Jara SM, Carson KA, Pai SI, et al. The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma. Surgery 2013; 154: 1272-1280.
22. Kwon JH, Nam ES, Shin HS, et al. P2X7 receptor expression in coexistence of papillary thyroid carcinoma with Hashimoto's thyroiditis. Korean J Pathol 2014; 48: 30-35.
23. Dvorkin S, Robenshtok E, Hirsch D, et al. Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. J Clin Endocrinol Metab 2013; 98: 2409-2414.
24. Buyukasik O, Hasdemir AO, Yalcin E, et al. The association between thyroid malignancy and chronic lymphocytic thyroiditis: Should it alter the surgical approach? Endokrynol Pol 2011; 62: 303-308.
25. Bradly DP, Reddy V, Prinz RA, Gattuso P. Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 2009; 146: 1099-1104.
26. McLeod DS, Watters KF, Carpenter AD, et al. Thyrotropin and thyroid cancer diagnosis: A systematic review and dose-response meta-Analysis. J Clin Endocrinol Metab 2012; 97: 2682-2692.
27. Paparodis R, Imam S, Todorova-Koteva K, et al. Hashimoto's thyroiditis pathology and risk for thyroid cancer. Thyroid 2014; 24: 1107-1114.
28. Santoro M, Sabino N, Ishizaka Y, et al. Involvement of RET oncogene in human tumours: Specificity of RET activation to thyroid tumours. Br J Cancer 1993; 68: 460-464.
29. Sheils OM, O'Eary JJ, Uhlmann V, et al. ret/PTC-1 activation in Hashimoto thyroiditis. Int J Surg Pathol 2000; 8: 185-189.
30. Mechler C, Bounacer A, Suarez H, et al. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements. Br J Cancer 2001; 85: 1831-1837.
31. Kim KH, Suh KS, Kang DW, Kang DY. Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis. Pathol Int 2005; 55: 540-545.
32. Sargent R, LiVolsi V, Murphy J, et al. BRAF mutation is unusual in chronic lymphocytic thyroiditis-Associated papillary thyroid carcinomas and absent in nonneoplastic nuclear atypia of thyroiditis. Endocr Pathol 2006; 17: 235-241.
33. Anderson CE, Graham C, Herriot MM, et al. CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto's thyroiditis. Histopathology 2009; 55: 683-686.
34. Unger P, Ewart M, Wang BY, et al. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: A pathobiologic link? Hum Pathol 2003; 34: 764-769.
35. Fan CY, Liu KL, Huang HY, et al. Frequent allelic imbalance and loss of protein expression of the DNA repair gene hOGG1 in head and neck squamous cell carcinoma. Lab Invest 2001; 81: 1429-1438.
36. Royer MC, Zhang H, Fan CY, Kokoska MS. Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: An analysis of hOGG1 loss of heterozygosity. Arch Otolaryngol Head Neck Surg 2010; 136: 240-242.
37. Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol 1999; 26: 316-323.
38. Pedersen RK, Pedersen NT. Primary non-Hodgkin's lymphoma of the thyroid gland: A population based study. Histopathology 1996; 28: 25-32.
39. Graff-Baker A, Roman SA, Thomas DC, et al. Prognosis of primary thyroid lymphoma: Demographic, clinical, and pathologic predictors of survival in 1408 cases. Surgery 2009; 146: 1105-1115.
40. Widder S, Pasieka JL. Primary thyroid lymphomas. Curr Treat Options Oncol 2004; 5: 307-313.
41. Moshynska OV, Saxena A. Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma. J Clin Pathol 2008; 61: 438-444.
42. Takakuwa T, Miyauchi A, Aozasa K. Aberrant somatic hypermutations in thyroid lymphomas. Leuk Res 2009; 33: 649-654.